N02BE04 Bucetin N02BE05 Propacetamol N02BE51 Paracetamol, combinations excluding psycholeptics N02BE53 Phenacetin, combinations excluding psycholeptics N02BE54 Bucetin, combinations excluding psycholeptics N02BE71 Paracetamol, combinations with psycholeptics N02BE73 Phenacetin, combinations with psycholeptics N02BE74 Bucetin, combinations with psycholeptics N02BF Gabapentinoids N02BF01 Gabapentin N02BF02 Pregabalin N02BF03 Mirogabalin N02BG Other analgesics and antipyretics N02BG02 Rimazolium N02BG03 Glafenine N02BG04 Floctafenine N02BG05 Viminol N02BG06 Nefopam N02BG07 Flupirtine N02BG08 Ziconotide N02BG09 Methoxyflurane N02BG10 Cannabinoids (includes nabiximols) N02BG12 Tanezumab QN02BG90 Frunevetmab QN02BG91 Bedinvetmab N02C Antimigraine preparations N02CA Ergot alkaloids N02CA01 Dihydroergotamine N02CA02 Ergotamine N02CA04 Methysergide N02CA07 Lisuride N02CA51 Dihydroergotamine, combinations N02CA52 Ergotamine, combinations excluding psycholeptics N02CA72 Ergotamine, combinations with psycholeptics N02CB Corticosteroid derivatives N02CB01 Flumedroxone N02CC Selective serotonin (5-HT1) agonists N02CC01 Sumatriptan N02CC02 Naratriptan N02CC03 Zolmitriptan N02CC04 Rizatriptan N02CC05 Almotriptan N02CC06 Eletriptan N02CC07 Frovatriptan N02CC08 Lasmiditan N02CD Calcitonin gene-related peptide (CGRP) antagonists N02CD01 Erenumab N02CD02 Galcanezumab N02CD03 Fremanezumab N02CD04 Ubrogepant N02CD05 Eptinezumab N02CD06 Rimegepant N02CD07 Atogepant N02CX Other antimigraine preparations N02CX01 Pizotifen N02CX02 Clonidine N02CX03 Iprazochrome N02CX05 Dimetotiazine N02CX06 Oxetorone References N02